Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Bernadet T. Santema, Michelle M. Y. Chan, Jasper Tromp, Martin Dokter, Haye H. van der Wal, Johanna E. Emmens, Janny Takens, Nilesh J. Samani, Leong L. Ng, Chim C. Lang, Peter van der Meer, Jozine M. Ter Maaten, Kevin Damman, Kenneth Dickstein, John G. Cleland, Faiez Zannad, Stefan D. Anker, Marco Metra, Pim van der Harst, Rudolf A. de BoerDirk J. van Veldhuisen, Michiel Rienstra, Carolyn S. P. Lam, Adriaan A. Voors (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

52 Downloads (Pure)

Abstract

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Original languageEnglish
Pages (from-to)1351-1351
Number of pages1
JournalClinical Research in Cardiology
Volume110
Issue number8
Early online date3 Nov 2020
DOIs
Publication statusPublished - Aug 2021

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure'. Together they form a unique fingerprint.

Cite this